396 related articles for article (PubMed ID: 19175868)
1. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection.
Gonzalez SA; Fiel MI; Sauk J; Canchis PW; Liu RC; Chiriboga L; Yee HT; Jacobson IM; Talal AH
J Viral Hepat; 2009 Feb; 16(2):141-8. PubMed ID: 19175868
[TBL] [Abstract][Full Text] [Related]
2. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
[TBL] [Abstract][Full Text] [Related]
3. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
4. Slight activation of nuclear factor kappa-B is associated with increased hepatic stellate cell apoptosis in human schistosomal fibrosis.
Braz MM; Ramalho FS; Cardoso RL; Zucoloto S; Costa RS; Ramalho LN
Acta Trop; 2010 Jan; 113(1):66-71. PubMed ID: 19781518
[TBL] [Abstract][Full Text] [Related]
5. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
[TBL] [Abstract][Full Text] [Related]
6. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
[TBL] [Abstract][Full Text] [Related]
7. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
8. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts.
Ozdemir BH; Bilezikçi B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
[TBL] [Abstract][Full Text] [Related]
11. Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia.
Carmack S; Taddei T; Robert ME; Mistry P; Jain D
Am J Gastroenterol; 2008 Mar; 103(3):705-11. PubMed ID: 17970837
[TBL] [Abstract][Full Text] [Related]
12. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
[TBL] [Abstract][Full Text] [Related]
14. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of CD38 positive hepatic stellate cell count for assessing disease activity and fibrosis in patients with chronic hepatitis.
Abdeen SM; Olusi SO; Askar HA; Thalib L; Al-Azemi A; George S
Acta Histochem; 2009; 111(6):520-30. PubMed ID: 18829073
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
17. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
18. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
[TBL] [Abstract][Full Text] [Related]
19. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
20. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]